The RSU award will vest in equal annual installments on the first four anniversaries of February 15, 2025, subject to the employee’s continued service with Mersana on each such vesting date. The RSU ...
Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company, has appointed Lisa Wyman as the Chief Technical and ...
of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to ...
Ensuring hypertext links are accessible is a fundamental aspect of web accessibility. Well-written link text plays an important part in helping users navigate your content and perform tasks. If links ...
This page features the latest news about the Mersana Therapeutics stock. MRSN stock touches 52-week low at $0.56 amid market challenges Mersana Therapeutics Inc . (NASDAQ:MRSN) stock has reached a ...
The "Antibody Drug Conjugates Market Report 2025-2035" has been added to ResearchAndMarkets.com's offering. World revenue for the Antibody Drug Conjugates Market is set to surpass US$16 billion in ...
When you try to connect with Xbox, a Smart TV or a Windows app with your Microsoft account, it gets little tricky as you need to go through a couple of links to ...
Bala Mohan, the Senior Vice President and Chief Development Officer at Mersana Therapeutics, Inc. (NASDAQ:MRSN), recently sold shares of the company as per a filing with the Securities and ...
The Bruhat Bengaluru Mahanagara Palike (BBMP) has now introduced a system for issuing e-khatas to bring five lakh properties into the tax bracket To streamline the property registration process ...
Hosted on MSN26d
Mersana therapeutics VP Mandelia sells $1,128 in stockCAMBRIDGE, MA—Mersana Therapeutics, Inc. (NASDAQ:MRSN) recently reported that Ashish Mandelia, the company's Vice President and Chief Accounting Officer, executed a sale of common stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results